According to Sonoma Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is NZ$29.11 Million. In 2024 the company made a revenue of NZ$24.77 Million an increase over the revenue in the year 2023 that were of NZ$19.46 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.